NCT00910858
- Conditions
- Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Clinical trial condition
Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)
Explore clinical trials studying Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS). Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies